Rosacea
Showing 1 - 25 of 483
Rosacea Trial in Bern (KTP laser, Ivermectin 1% cream)
Not yet recruiting
- Rosacea
- KTP laser
- Ivermectin 1% cream
-
Bern, SwitzerlandDepartment of dermatology, University Hospital Inselspital, Bern
Sep 12, 2023
Rosacea Trial (Barrier Renew)
Not yet recruiting
- Rosacea
- Barrier Renew
- (no location specified)
Jul 18, 2023
Assessment of Rosacea Patients' Clinical Trial Experiences
Not yet recruiting
- Rosacea
- (no location specified)
Feb 17, 2023
Rosacea, Systemic Inflammation Trial in Sacramento (Skin Barrier Oral Supplement)
Not yet recruiting
- Rosacea
- Systemic Inflammation
- Skin Barrier Oral Supplement
-
Sacramento, CaliforniaIntegrative Skin and Research
Oct 2, 2023
Rosacea, Papulopustular Rosacea Trial in Washington (drug, device, other)
Completed
- Rosacea
- Papulopustular Rosacea
- Aminolevulinic acid topical solution 20%
- +2 more
-
Washington, District of ColumbiaMedical Faculty Associates - George Washington University
Dec 1, 2022
Acne, Melasma, Rosacea Trial in Sacramento (No Intervention)
Recruiting
- Acne
- +3 more
- No Intervention
-
Sacramento, CaliforniaIntegrative Skin and Research
Jul 4, 2023
Seborrheic Dermatitis, Papulopustular Rosacea Trial in New York (PF-07038124, Placebo Ointment)
Recruiting
- Seborrheic Dermatitis
- Papulopustular Rosacea
- PF-07038124
- Placebo Ointment
-
New York, New YorkIcahn School of Medicine at Mount Sinai
Aug 22, 2023
Rosacea Trial in Jakarta, Depok (Metronidazole 1% Cream,Top, Placebo)
Not yet recruiting
- Rosacea
- Metronidazole 1% Cream,Top
- Placebo
-
Jakarta, DKI Jakarta, Indonesia
- +1 more
May 14, 2023
Rosacea, Rosacea Papular Type, Rosacea, Papulopustular Trial in Spain (Probiotic mixture, Placebo)
Recruiting
- Rosacea
- +2 more
- Probiotic mixture
- Placebo
-
Vigo, Pontevedra, Spain
- +3 more
Apr 4, 2023
Rosacea Trial in Hamburg (532nm KTP, 585nm PDL)
Recruiting
- Rosacea
- 532nm KTP
- 585nm PDL
-
Hamburg, GermanyLaser Department, University Medical-Center Hamburg-Eppendorf
Mar 5, 2023
Rosacea, Erythematotelangiectatic Trial in Albany (Trametinib)
Recruiting
- Rosacea, Erythematotelangiectatic
-
Albany, New YorkSamuel S. Stratton VA Medical Center
Nov 9, 2022
Acne Rosacea Trial in Austin (Topical Powder, Placebo Topical Powder)
Active, not recruiting
- Acne Rosacea
- Topical Powder
- Placebo Topical Powder
-
Austin, TexasDermata Investigational Site
Dec 7, 2022
M89PF in Rosacea Associated With Erythema and Sensitive Skin
Completed
- Rosacea
-
Milan, ItalyISPE
Sep 28, 2022
Papulopustular Rosacea Trial in Canada (Lotilaner Gel, 2.0%, Vehicle control gel)
Recruiting
- Papulopustular Rosacea
- Lotilaner Gel, 2.0%
- Vehicle control gel
-
Oakville, Ontario, Canada
- +4 more
Apr 20, 2023
Rosacea Trial (Bromonide 0.33% gel, Intense Pulsed Light (M22))
Withdrawn
- Rosacea
- Bromonide 0.33% gel
- Intense Pulsed Light (M22)
-
Petaẖ Tiqwa, IsraelRabin Medical Center
Oct 27, 2022
Rosacea, Papulopustular Trial in New City (cold atmospheric plasma)
Recruiting
- Rosacea, Papulopustular
- cold atmospheric plasma
-
New City, New YorkThe Skin Center Dermatology Group
Oct 27, 2022
Ocular Rosacea, Antimicrobial Resistance Trial in San Francisco (Doxycycline 40 MG Oral Tablet, Doxycycline 100 MG Oral Tablet,
Not yet recruiting
- Ocular Rosacea
- Antimicrobial Resistance
- Doxycycline 40 MG Oral Tablet
- +2 more
-
San Francisco, CaliforniaUniversity of California, San Farncisco
Jul 7, 2022
Papulopustular Rosacea Trial in Carrollton (Oracea)
Completed
- Papulopustular Rosacea
-
Carrollton, TexasStephens & Associates Dallas Research Center
Jul 28, 2022
Rosacea Trial (treatment)
Not yet recruiting
- Rosacea
- treatment
- (no location specified)
Jun 1, 2022
Rosacea, Ocular Rosacea, Cutaneous Rosacea Trial in Sacramento (Doxycycline)
Active, not recruiting
- Rosacea
- +2 more
-
Sacramento, CaliforniaUniversity of California-Davis, Department of Dermatology
Feb 24, 2022
Papulopustular Rosacea Trial in Sacramento (Encapsulated Benzoyl Peroxide Cream)
Completed
- Papulopustular Rosacea
- Encapsulated Benzoyl Peroxide Cream
-
Sacramento, CaliforniaIntegrative Skin Science and Research (ISSR)
Dec 21, 2022
Rosacea Trial in Lexington (doxycycline (Oracea®) 40 mg modified release as monotherapy, doxycycline (Oracea®) 40 mg modified
Completed
- Rosacea
- doxycycline (Oracea®) 40 mg modified release as monotherapy
- doxycycline (Oracea®) 40 mg modified release as add-on therapy
-
Lexington, KentuckyREGISTRAT® - MAP1, Inc. (CRO)
Jul 28, 2022
Erythematotelangiectatic Rosacea Trial in Hanzhou (PDL(595nm), IPL(DPL), IPL(M22 590))
Recruiting
- Erythematotelangiectatic Rosacea
- PDL(595nm)
- +3 more
-
Hanzhou, Zhejiang, ChinaThe Second Affiliated Hospital of Zhejiang University of Medicin
Apr 30, 2022
Erythema, Rosacea Trial in United States (CD07805/47 gel 0.5%/CD07805/47 Vehicle, azelaic acid gel 15%)
Completed
- Erythema
- Rosacea
- CD07805/47 gel 0.5%/CD07805/47 Vehicle
- azelaic acid gel 15%
-
Evansville, Indiana
- +3 more
Jul 28, 2022